This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
How can we drive transformation in oncology care?
Evaluating the Enhancing Oncology Model (EOM)
Challenge
The CMS Innovation Center’s voluntary Enhancing Oncology Model (EOM) aims to drive transformation and improve care coordination, quality, and health outcomes for patients with cancer while also holding oncology practices accountable for total costs of care to make cancer care more affordable and accessible for beneficiaries and Medicare.
The payment structure used for traditional Medicare fee-for-service (FFS) oncology care can potentially create financial incentives that lead to high cost but low value care and a focus on the disease and not the person, which can lead to fragmented, uncoordinated care.
The model will test how to improve health care providers’ ability to design cancer care centered on patients, consider patients’ unique needs, and deliver cancer care in a way that will generate the best possible patient outcomes.
Solution
Westat supports the Lewin Group in conducting an independent, mixed-methods evaluation of EOM, assessing whether EOM achieves its intended goals of transforming care for cancer patients and practices, reducing Medicare spending, and maintaining or improving quality of care.
Westat will provide oncology care expertise and contribute to key tasks, including:
- Management of a technical expert panel comprising practicing clinicians who specialize in the cancer types included in the Model
- Primary data collection involving surveys of and interviews with Medicare beneficiaries
- Site visits and surveys of oncology practices participating in the Model
Westat will also support analysis of Medicare claims, SEER-Medicare, and state-level cancer registry data.
Results
EOM’s objective is to improve the experience of people and their families living with and surviving cancer. The model aligns with the priorities of supporting patients, caregivers, and survivors, learning from all patients, and targeting the right treatments for the right patients.
EOM aims to enhance the quality of care and coordination for cancer patients while also ensuring that oncology practices remain accountable for the total costs of care. This will make cancer care more affordable and accessible to beneficiaries and Medicare, which are significant priorities for the CMS Innovation Center (CMMI).
Learn more: Enhancing Oncology Model
-
Expert Interview
Why Are People Reluctant to Share Health App Data?May 2025
In an age where smart watches track our heart rate, apps detect our sleep patterns, and digital platforms monitor the calories we burn, the potential…
-
Expert Interview
Fine-Tuning LLMs to Improve Adverse Drug Event Detection and ReportingApril 2025
The expedient, accurate detection of the severity of adverse drug events (ADEs) remains a serious challenge. Despite technological advancements, data-driven models often fail to precisely…
-
Perspective
Leveraging Quantum Computing to Accelerate Biomedical InnovationsMarch 2025
Quantum computing is poised to revolutionize health care and biomedical research, making a tangible impact on Americans’ everyday lives. By rapidly analyzing vast genetic and…